AlgometRx, Inc.
PrivateLast Round
Grant
Nov 1, 2024
Total Funding Raised
$11.24M
Company Overview
AlgometRx, Inc. operates in Healthcare & Life Sciences and is based in Washington D.C.. Its latest recorded funding round was a Grant round in November 2024.
AlgometRx, Inc. is a medical device company that develops a non-invasive, handheld diagnostic platform designed to objectively measure pain type and intensity through pupillary response analysis.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Healthcare Analytics, Clinical Trials, Medical AI
Business Model
B2B
Customer Profile
Hardware Sales, Government Contracts
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
AlgometRx, Inc. Comparables
Compare AlgometRx, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| BioTraceIT | 85% | |
| IDMED | 82% | |
| PainQx | 81% |
For institutional investors. Book with your work email.
AlgometRx, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Nov 1, 2024 | ||||
| Grant | Sep 1, 2022 | ||||
| Early Funding | May 18, 2021 | ||||
| Grant | Sep 10, 2019 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
AlgometRx, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Cancer Institute | Grant |
| National Institute on Drug Abuse | Grant |
| National Institute of Arthritis and Musculoskeletal and Skin Diseases | Grant |
| ARPA-H | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 19, 2026
Monthly visitors increased 32% MoM, reaching 2.3K.
- Mar 3, 2026
Monthly visitors increased 93% MoM.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- is_developingOct 22, 2026
AlgometRx, Inc. is developing the Nociometer, a device designed to provide an objective, quantitative assessment of pain-related physiology across clinical settings.
For institutional investors. Book with your work email.
AlgometRx, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about AlgometRx, Inc.'s valuation, stock price, and market status.
Is AlgometRx, Inc. a public or private company?
AlgometRx, Inc. is a private company.
What is the current stock price of AlgometRx, Inc.?
AlgometRx, Inc. is a private company, so its shares have no public market price. Caplight tracks AlgometRx, Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is AlgometRx, Inc. worth (valuation)?
Valuation information for AlgometRx, Inc. is not publicly available.
Can I buy AlgometRx, Inc. stock?
AlgometRx, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was AlgometRx, Inc.'s last funding round?
AlgometRx, Inc.'s most recent funding round was Grant on November 1, 2024.
Who are the main investors in AlgometRx, Inc.?
Key investors in AlgometRx, Inc. include National Cancer Institute, National Institute on Drug Abuse, National Institute of Arthritis and Musculoskeletal and Skin Diseases, ARPA-H.
Will AlgometRx, Inc. IPO soon?
No public IPO plans have been announced for AlgometRx, Inc..
How can I track AlgometRx, Inc. secondary market activity?
Caplight tracks bids, offers, and trades in AlgometRx, Inc.'s shares on secondary markets.